Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (633)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
85
2025
278
13.230
 Why?
Papillomavirus Infections
19
2025
168
2.990
 Why?
Ovarian Neoplasms
37
2024
450
2.820
 Why?
Endometrial Neoplasms
34
2019
137
2.430
 Why?
Uterine Cervical Dysplasia
16
2017
49
2.420
 Why?
Carcinoma, Squamous Cell
31
2018
325
2.040
 Why?
Gene Expression Regulation, Neoplastic
19
2025
830
1.930
 Why?
Human papillomavirus 16
8
2019
44
1.740
 Why?
Papillomaviridae
17
2025
103
1.620
 Why?
Female
191
2025
26981
1.600
 Why?
Gene Expression Profiling
9
2021
1029
1.560
 Why?
DNA Methylation
22
2025
551
1.350
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
1003
1.310
 Why?
Genital Neoplasms, Female
10
2018
41
1.200
 Why?
Human papillomavirus 18
5
2019
9
1.180
 Why?
Humans
192
2025
50389
1.170
 Why?
Genetic Predisposition to Disease
13
2024
509
1.130
 Why?
Adult
92
2024
13568
1.100
 Why?
Middle Aged
99
2024
12460
1.040
 Why?
Neoplasm Staging
41
2019
750
1.040
 Why?
Adenocarcinoma
18
2018
402
1.000
 Why?
Polymorphism, Single Nucleotide
10
2019
482
0.980
 Why?
MicroRNAs
7
2019
350
0.950
 Why?
Fluorodeoxyglucose F18
15
2022
190
0.950
 Why?
DNA-Binding Proteins
9
2021
424
0.940
 Why?
Neoplasm Recurrence, Local
19
2024
634
0.930
 Why?
Carcinoma
12
2010
139
0.910
 Why?
Oncogene Proteins, Viral
4
2019
52
0.860
 Why?
Radiopharmaceuticals
14
2022
205
0.800
 Why?
Cervix Uteri
7
2017
48
0.800
 Why?
Repressor Proteins
4
2019
149
0.800
 Why?
Alphapapillomavirus
1
2021
13
0.760
 Why?
DNA, Viral
6
2019
133
0.740
 Why?
Cell Line, Tumor
18
2021
1399
0.730
 Why?
Immunologic Factors
2
2014
111
0.720
 Why?
Neoplasm Invasiveness
15
2020
269
0.700
 Why?
Neoplasms
8
2022
1237
0.690
 Why?
Genetic Markers
8
2017
103
0.670
 Why?
Genes, Tumor Suppressor
8
2007
73
0.670
 Why?
Aged
70
2024
9590
0.670
 Why?
Neoplasm Proteins
10
2019
321
0.660
 Why?
Immunoglobulins
3
2017
80
0.660
 Why?
Genomics
4
2018
284
0.630
 Why?
Gene Silencing
5
2018
114
0.620
 Why?
Biomedical Research
1
2022
242
0.620
 Why?
Vascular Endothelial Growth Factor A
2
2017
183
0.560
 Why?
Cisplatin
7
2022
275
0.550
 Why?
Proteomics
1
2019
299
0.550
 Why?
Aged, 80 and over
36
2024
3180
0.540
 Why?
Promoter Regions, Genetic
12
2020
467
0.530
 Why?
HLA-C Antigens
2
2018
4
0.520
 Why?
Receptors, KIR
2
2018
13
0.520
 Why?
Positron-Emission Tomography
11
2013
289
0.500
 Why?
Ubiquitin Thiolesterase
2
2021
17
0.500
 Why?
Tumor Virus Infections
4
2006
46
0.500
 Why?
Alleles
6
2025
253
0.500
 Why?
Lymph Nodes
10
2010
258
0.500
 Why?
Microsatellite Repeats
14
2007
37
0.490
 Why?
Disease-Free Survival
17
2013
450
0.490
 Why?
Hysterectomy
15
2022
88
0.480
 Why?
Gynecologic Surgical Procedures
4
2010
28
0.480
 Why?
Virus Integration
3
2025
9
0.470
 Why?
Granulosa Cell Tumor
2
2024
2
0.460
 Why?
Phenotype
4
2016
736
0.460
 Why?
Prognosis
19
2021
1979
0.450
 Why?
Lymphatic Metastasis
14
2019
227
0.440
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.440
 Why?
Immunohistochemistry
13
2024
975
0.440
 Why?
Nuclear Proteins
8
2009
244
0.430
 Why?
Loss of Heterozygosity
10
2007
77
0.430
 Why?
Ovary
2
2008
114
0.410
 Why?
Membrane Proteins
3
2005
348
0.410
 Why?
Genotype
9
2018
539
0.400
 Why?
Cell Movement
5
2021
246
0.400
 Why?
Survival Analysis
14
2021
671
0.400
 Why?
STAT3 Transcription Factor
3
2021
80
0.390
 Why?
Ultrasonic Therapy
3
2001
34
0.390
 Why?
Peritoneal Neoplasms
4
2008
62
0.390
 Why?
Carcinoma, Endometrioid
6
2014
38
0.380
 Why?
Genes, p53
2
2010
51
0.380
 Why?
Cell Proliferation
6
2021
989
0.370
 Why?
Risk Factors
13
2019
3692
0.370
 Why?
Signal Transduction
8
2021
1625
0.360
 Why?
Uterine Neoplasms
5
2009
60
0.360
 Why?
Mutation
12
2018
1292
0.360
 Why?
Ascites
2
2008
29
0.350
 Why?
Carboplatin
2
2009
51
0.350
 Why?
Antineoplastic Agents
9
2014
1178
0.350
 Why?
Antibodies, Monoclonal
5
2021
462
0.350
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
13
0.350
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
12
0.350
 Why?
Cohort Studies
13
2024
1426
0.350
 Why?
Disease Progression
6
2020
823
0.340
 Why?
GTPase-Activating Proteins
1
2009
23
0.340
 Why?
Membrane Glycoproteins
2
2009
244
0.340
 Why?
Base Sequence
8
2019
657
0.340
 Why?
DNA, Neoplasm
11
2006
146
0.330
 Why?
Chromosomes, Human, Pair 11
3
2005
54
0.330
 Why?
Matrix Metalloproteinase 9
1
2009
87
0.330
 Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.330
 Why?
Brachytherapy
9
2014
46
0.320
 Why?
Proto-Oncogene Proteins c-myc
2
2021
50
0.320
 Why?
Combined Modality Therapy
11
2010
641
0.320
 Why?
Abdominal Neoplasms
1
2009
16
0.320
 Why?
DNA Repair
11
2007
186
0.320
 Why?
Genome, Human
3
2025
111
0.320
 Why?
Retrospective Studies
33
2024
6223
0.320
 Why?
Laser Coagulation
1
2009
26
0.310
 Why?
Drug Administration Schedule
10
2013
369
0.310
 Why?
Deoxycytidine
4
2006
28
0.300
 Why?
Homeodomain Proteins
2
2006
87
0.300
 Why?
RNA-Binding Proteins
2
2021
120
0.300
 Why?
Microsatellite Instability
5
2019
18
0.300
 Why?
Protozoan Proteins
1
2008
32
0.300
 Why?
Germ-Line Mutation
3
2024
63
0.300
 Why?
Laparoscopy
3
2022
170
0.300
 Why?
Kaplan-Meier Estimate
6
2019
466
0.300
 Why?
Drug Resistance, Neoplasm
6
2016
318
0.290
 Why?
Ovariectomy
7
2010
113
0.290
 Why?
Antigens, CD
2
2007
216
0.280
 Why?
Chromosomes, Human, Pair 3
4
2001
19
0.280
 Why?
Heart Arrest
1
2009
152
0.280
 Why?
SOXC Transcription Factors
2
2019
13
0.280
 Why?
Polymerase Chain Reaction
9
2010
456
0.280
 Why?
Receptors, Estrogen
3
2024
130
0.270
 Why?
Topotecan
5
2013
17
0.270
 Why?
POU Domain Factors
1
2006
1
0.270
 Why?
Vulvar Neoplasms
5
2002
58
0.260
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
409
0.260
 Why?
Neoplasm Metastasis
5
2021
235
0.260
 Why?
HeLa Cells
3
2021
257
0.260
 Why?
Registries
6
2010
539
0.260
 Why?
Anemia
3
2020
66
0.250
 Why?
Genome, Viral
2
2025
79
0.250
 Why?
Young Adult
7
2018
4064
0.250
 Why?
Survival Rate
10
2009
915
0.250
 Why?
Vaginal Smears
6
2006
28
0.250
 Why?
Breast Neoplasms
5
2018
1189
0.240
 Why?
Gene Rearrangement
1
2025
74
0.230
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
578
0.230
 Why?
Chromosome Aberrations
1
2006
295
0.230
 Why?
HSP70 Heat-Shock Proteins
1
2004
62
0.230
 Why?
Receptors, Androgen
1
2024
46
0.220
 Why?
Receptors, Progesterone
1
2024
63
0.220
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.220
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.220
 Why?
Quinazolines
1
2003
32
0.220
 Why?
Oncostatin M
2
2021
5
0.220
 Why?
Antigens, Neoplasm
1
2004
146
0.220
 Why?
Genome-Wide Association Study
2
2017
163
0.220
 Why?
Polymorphism, Genetic
5
2018
181
0.210
 Why?
Small Cell Lung Carcinoma
1
2023
27
0.210
 Why?
Omentum
1
2002
15
0.210
 Why?
Case-Control Studies
7
2019
1148
0.210
 Why?
Treatment Outcome
23
2014
5230
0.210
 Why?
Chromosome Deletion
3
2000
140
0.210
 Why?
Linkage Disequilibrium
3
2017
36
0.200
 Why?
Proto-Oncogene Proteins c-akt
2
2014
155
0.200
 Why?
Neoadjuvant Therapy
2
2022
119
0.200
 Why?
Antibodies, Monoclonal, Humanized
5
2013
224
0.200
 Why?
Genetic Variation
4
2019
215
0.200
 Why?
Tumor Microenvironment
2
2021
223
0.200
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.200
 Why?
Base Pair Mismatch
5
2006
22
0.190
 Why?
CA-125 Antigen
3
2008
17
0.190
 Why?
Suction
1
2001
23
0.190
 Why?
Chemoradiotherapy
1
2022
43
0.190
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.190
 Why?
Postoperative Complications
3
2022
1035
0.190
 Why?
Smoking
1
2005
508
0.190
 Why?
Radiotherapy, Conformal
2
2014
53
0.190
 Why?
Proteins
5
2008
350
0.190
 Why?
Carcinoma in Situ
2
2013
73
0.190
 Why?
Colorectal Neoplasms
3
2002
256
0.180
 Why?
Adaptor Proteins, Signal Transducing
8
2007
197
0.180
 Why?
Antimetabolites, Antineoplastic
2
2002
37
0.180
 Why?
Gene Regulatory Networks
2
2019
107
0.180
 Why?
Fetofetal Transfusion
1
2020
6
0.180
 Why?
Polycythemia
1
2020
9
0.180
 Why?
Minority Groups
1
2022
130
0.180
 Why?
Pregnancy, Twin
1
2020
8
0.180
 Why?
Radiotherapy
3
2010
124
0.180
 Why?
Twins, Monozygotic
1
2020
16
0.180
 Why?
Sarcoma
3
2009
66
0.180
 Why?
Lymph Node Excision
7
2019
138
0.180
 Why?
Genetic Diseases, Inborn
1
2000
23
0.180
 Why?
Transcriptome
2
2020
316
0.180
 Why?
Patient Satisfaction
2
2006
280
0.170
 Why?
Receptor, erbB-3
1
2020
1
0.170
 Why?
Furin
1
2020
3
0.170
 Why?
HLA-DQ Antigens
1
2000
3
0.170
 Why?
Phosphoproteins
2
2016
117
0.170
 Why?
Receptor, IGF Type 1
1
2020
20
0.170
 Why?
Mice, Nude
4
2021
252
0.170
 Why?
Tomography, X-Ray Computed
7
2013
1160
0.170
 Why?
Tumor Cells, Cultured
7
2021
462
0.170
 Why?
RNA, Neoplasm
3
2007
45
0.170
 Why?
Prenatal Diagnosis
1
2020
108
0.170
 Why?
Antibodies, Neoplasm
1
2019
28
0.170
 Why?
Students
1
2022
222
0.170
 Why?
Papillomavirus E7 Proteins
2
2017
31
0.160
 Why?
Adolescent
13
2018
6475
0.160
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.160
 Why?
Reproducibility of Results
2
2022
1201
0.160
 Why?
Placenta
1
2020
135
0.160
 Why?
Follow-Up Studies
13
2019
2219
0.160
 Why?
Indocyanine Green
1
2019
34
0.160
 Why?
Doxorubicin
4
2009
234
0.150
 Why?
Fallopian Tube Neoplasms
3
2008
14
0.150
 Why?
Salvage Therapy
3
2008
136
0.150
 Why?
Decision Making
1
2001
273
0.150
 Why?
Cyclooxygenase 2
2
2017
43
0.150
 Why?
Lung Neoplasms
2
2023
600
0.150
 Why?
Sequence Analysis, DNA
1
2019
237
0.150
 Why?
Transcription Factors
1
2021
566
0.150
 Why?
HLA-DRB1 Chains
1
2017
5
0.150
 Why?
HLA-B Antigens
1
2017
7
0.150
 Why?
Metabolic Networks and Pathways
1
2018
92
0.150
 Why?
DNA Copy Number Variations
1
2018
109
0.150
 Why?
Tumor Suppressor Proteins
3
2005
127
0.140
 Why?
Receptors, Vitronectin
1
1997
1
0.140
 Why?
Carcinoma, Adenosquamous
3
2009
8
0.140
 Why?
Proto-Oncogene Proteins
5
2004
156
0.140
 Why?
DNA Mutational Analysis
9
2005
176
0.140
 Why?
Bayes Theorem
1
2017
106
0.140
 Why?
Interleukin-10
1
2017
84
0.140
 Why?
Adipose Tissue
1
2019
191
0.140
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
17
0.140
 Why?
In Situ Hybridization
3
2008
64
0.140
 Why?
Leukocytes, Mononuclear
1
2017
113
0.140
 Why?
Protein Binding
1
2019
657
0.140
 Why?
Animals
10
2021
13173
0.140
 Why?
Radiotherapy, Intensity-Modulated
2
2009
174
0.140
 Why?
Gene Expression Regulation, Viral
1
2017
48
0.140
 Why?
Risk Assessment
9
2019
1258
0.140
 Why?
Radiotherapy Dosage
8
2014
247
0.130
 Why?
Body Mass Index
3
2010
669
0.130
 Why?
Radiation Injuries
3
2008
111
0.130
 Why?
ROC Curve
1
2017
239
0.130
 Why?
Carrier Proteins
7
2006
302
0.130
 Why?
Taxoids
3
2006
37
0.130
 Why?
Diagnosis, Differential
4
2024
1042
0.130
 Why?
Biopsy
5
2006
592
0.130
 Why?
Estrogens
1
2017
222
0.130
 Why?
Prospective Studies
10
2019
2414
0.130
 Why?
Colposcopy
3
2006
18
0.130
 Why?
Molecular Sequence Data
5
2009
799
0.130
 Why?
Wound Healing
2
2018
203
0.130
 Why?
Cells, Cultured
2
2017
1589
0.120
 Why?
Double-Blind Method
1
2017
682
0.120
 Why?
Mice
6
2021
5688
0.120
 Why?
Carcinosarcoma
3
2019
18
0.120
 Why?
Algorithms
1
2019
618
0.120
 Why?
Protein Kinase Inhibitors
2
2014
205
0.120
 Why?
Apoptosis
2
2021
1094
0.120
 Why?
Ultrasonography, Doppler, Color
1
1995
32
0.120
 Why?
Sensitivity and Specificity
4
2006
875
0.120
 Why?
Dose-Response Relationship, Drug
6
2008
1356
0.120
 Why?
Aneurysm
1
1995
33
0.120
 Why?
Phosphatidylinositol 3-Kinases
2
2014
139
0.120
 Why?
DNA Primers
2
2006
208
0.120
 Why?
Platinum Compounds
4
2008
11
0.120
 Why?
Obesity
5
2010
1125
0.120
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.120
 Why?
Cyclohexanones
1
2014
5
0.110
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.110
 Why?
Embolization, Therapeutic
1
1995
88
0.110
 Why?
Transcriptional Activation
2
2019
121
0.110
 Why?
TOR Serine-Threonine Kinases
1
2014
77
0.110
 Why?
Camptothecin
3
2010
16
0.110
 Why?
Genetic Association Studies
1
2014
115
0.110
 Why?
Paclitaxel
4
2007
83
0.110
 Why?
Introns
1
2013
50
0.110
 Why?
Hypercalcemia
1
1993
33
0.110
 Why?
Decision Support Techniques
2
2010
71
0.110
 Why?
Chromosome Mapping
3
2005
158
0.110
 Why?
Pyridines
1
2014
132
0.100
 Why?
Cell Transformation, Neoplastic
2
2006
181
0.100
 Why?
Brain Neoplasms
1
2016
288
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
34
0.100
 Why?
Models, Genetic
1
2012
174
0.100
 Why?
Tomography, Emission-Computed
4
2005
53
0.100
 Why?
Groin
2
2002
16
0.100
 Why?
Keratinocytes
2
2006
91
0.100
 Why?
RNA, Messenger
4
2021
1101
0.100
 Why?
Glucose
1
2014
341
0.100
 Why?
Cystadenocarcinoma, Serous
2
2024
71
0.100
 Why?
Laser Therapy
1
1992
84
0.100
 Why?
Exons
3
2007
96
0.100
 Why?
Pyrazoles
2
2023
111
0.100
 Why?
Infusions, Intravenous
4
2006
213
0.100
 Why?
Heterozygote
2
2004
83
0.090
 Why?
Condylomata Acuminata
1
1991
4
0.090
 Why?
Magnetic Resonance Imaging
3
2014
1534
0.090
 Why?
Models, Statistical
1
2012
226
0.090
 Why?
Epithelium
2
2007
65
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
19
0.090
 Why?
Estrogen Antagonists
1
2010
21
0.090
 Why?
Ileal Diseases
1
1990
4
0.090
 Why?
Predictive Value of Tests
6
2010
934
0.090
 Why?
Leiomyoma
1
1990
25
0.090
 Why?
Cell Differentiation
2
2009
651
0.090
 Why?
Epigenesis, Genetic
2
2019
374
0.090
 Why?
Polymorphism, Restriction Fragment Length
1
2010
66
0.090
 Why?
Restriction Mapping
3
2006
33
0.090
 Why?
Gastrointestinal Hemorrhage
1
1990
79
0.080
 Why?
Colonic Neoplasms
2
2004
158
0.080
 Why?
Skin Transplantation
1
1990
43
0.080
 Why?
Down-Regulation
4
2020
343
0.080
 Why?
Age Factors
4
2006
1104
0.080
 Why?
Fluorouracil
2
2006
56
0.080
 Why?
Maximum Tolerated Dose
5
2010
40
0.080
 Why?
Endometrium
3
2019
40
0.080
 Why?
Urinary Bladder Diseases
1
2009
18
0.080
 Why?
Intestinal Diseases
1
2009
26
0.080
 Why?
Lasers, Gas
1
2009
7
0.080
 Why?
Embolism, Air
1
2009
12
0.080
 Why?
Transcription, Genetic
4
2019
371
0.080
 Why?
Lymphatic Vessels
1
2009
53
0.080
 Why?
Vaginal Neoplasms
2
2005
4
0.080
 Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
 Why?
Fluorine Radioisotopes
1
2008
24
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
 Why?
Infertility, Female
1
2008
18
0.080
 Why?
Haplotypes
2
2017
82
0.080
 Why?
Eimeria
1
2008
3
0.080
 Why?
Polyethylene Glycols
2
2006
86
0.080
 Why?
Up-Regulation
2
2020
449
0.080
 Why?
Ubiquitin
1
2008
45
0.080
 Why?
Cell Cycle Proteins
1
2009
168
0.070
 Why?
Angiogenesis Inhibitors
2
2006
182
0.070
 Why?
Tumor Burden
2
2021
131
0.070
 Why?
Cricetinae
1
2008
211
0.070
 Why?
Expressed Sequence Tags
1
2007
8
0.070
 Why?
Infusion Pumps
1
1987
13
0.070
 Why?
Fluorescent Antibody Technique
1
2007
112
0.070
 Why?
Diagnostic Imaging
1
2009
179
0.070
 Why?
Microdissection
1
2007
19
0.070
 Why?
Models, Biological
2
2008
723
0.070
 Why?
Precancerous Conditions
2
2005
83
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Aorta
3
2005
163
0.070
 Why?
Stromal Cells
1
2007
72
0.070
 Why?
Organ Specificity
2
2018
109
0.070
 Why?
Lasers
1
2007
107
0.070
 Why?
Codon
2
2003
47
0.070
 Why?
Pelvic Floor
1
2007
51
0.070
 Why?
Recombinant Proteins
1
2008
482
0.070
 Why?
RNA, Double-Stranded
1
2006
21
0.070
 Why?
Neutropenia
1
2007
114
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
19
0.070
 Why?
Tissue Fixation
1
2006
36
0.070
 Why?
Intestinal Perforation
2
2006
23
0.070
 Why?
Specimen Handling
1
2006
54
0.070
 Why?
Pulmonary Embolism
1
1987
98
0.070
 Why?
Head and Neck Neoplasms
2
2016
282
0.070
 Why?
Protein Kinases
1
2006
70
0.070
 Why?
Chromosomes, Artificial, Yeast
3
2000
7
0.060
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Proportional Hazards Models
4
2010
418
0.060
 Why?
Abdomen
1
2006
77
0.060
 Why?
Papillomavirus Vaccines
1
2006
67
0.060
 Why?
Neovascularization, Pathologic
1
2006
153
0.060
 Why?
Recurrence
4
2010
664
0.060
 Why?
Probability
4
2007
165
0.060
 Why?
Terminal Care
1
2005
46
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
51
0.060
 Why?
Male
11
2018
25718
0.060
 Why?
Cell Adhesion Molecules
1
2005
87
0.060
 Why?
Quinolines
1
2004
41
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
214
0.060
 Why?
Amyloid
1
2004
26
0.060
 Why?
Tissue Distribution
1
2004
167
0.060
 Why?
Genes, Viral
1
2003
38
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
234
0.060
 Why?
Lactones
1
2003
25
0.060
 Why?
Abdomen, Acute
1
2003
6
0.060
 Why?
Thrombospondins
1
2003
8
0.050
 Why?
Biopsy, Needle
4
2006
182
0.050
 Why?
Obesity, Morbid
1
2004
80
0.050
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
57
0.050
 Why?
Pyrimidinones
1
2023
19
0.050
 Why?
RNA, Viral
2
2016
123
0.050
 Why?
Fibroma
1
2003
39
0.050
 Why?
Clinical Competence
1
2006
397
0.050
 Why?
Neoplasms, Second Primary
1
2004
74
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
60
0.050
 Why?
Congenital Abnormalities
1
2004
115
0.050
 Why?
Uterine Hemorrhage
1
2002
11
0.050
 Why?
Age of Onset
2
2004
108
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
PTEN Phosphohydrolase
2
2019
54
0.050
 Why?
DNA, Ribosomal
1
2002
28
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
326
0.050
 Why?
Blood Transfusion, Autologous
1
2002
4
0.050
 Why?
Genital Diseases, Female
1
2002
17
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Postmenopause
1
2002
77
0.050
 Why?
Pregnancy
3
2020
2610
0.050
 Why?
Medical History Taking
1
2002
47
0.050
 Why?
Medical Records
1
2002
86
0.050
 Why?
Blood Donors
1
2002
31
0.050
 Why?
Complementary Therapies
1
2002
25
0.050
 Why?
Family Health
1
2002
78
0.050
 Why?
AU Rich Elements
1
2021
1
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
 Why?
RNA Stability
1
2021
24
0.050
 Why?
Cytokine Receptor gp130
1
2021
12
0.050
 Why?
3' Untranslated Regions
1
2021
53
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
25
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.050
 Why?
Blotting, Northern
2
2001
110
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
25
0.050
 Why?
Blotting, Southern
3
2002
43
0.050
 Why?
Xenograft Model Antitumor Assays
1
2021
213
0.050
 Why?
Internship and Residency
1
2006
444
0.050
 Why?
Phosphoric Monoester Hydrolases
1
2000
21
0.040
 Why?
Catheterization, Central Venous
1
2001
85
0.040
 Why?
Equipment Design
1
2001
290
0.040
 Why?
Blood Vessels
1
2001
71
0.040
 Why?
Uganda
1
2020
36
0.040
 Why?
Quality Improvement
1
2022
206
0.040
 Why?
Isoenzymes
1
2001
168
0.040
 Why?
Logistic Models
2
2017
900
0.040
 Why?
Incidence
3
2007
1017
0.040
 Why?
Risk Management
1
2000
32
0.040
 Why?
Physical Chromosome Mapping
1
2000
7
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Interviews as Topic
1
2001
263
0.040
 Why?
Patient Discharge
1
2022
322
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
13
0.040
 Why?
Cell Survival
1
2021
590
0.040
 Why?
DNA Repair Enzymes
1
1999
42
0.040
 Why?
Adenosine Triphosphatases
1
1999
87
0.040
 Why?
Cell Nucleus
1
2019
186
0.040
 Why?
Molecular Targeted Therapy
1
2019
121
0.040
 Why?
Cross-Sectional Studies
1
2024
1590
0.040
 Why?
Regression Analysis
3
2006
396
0.040
 Why?
Pregnancy Outcome
1
2020
237
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
4
0.040
 Why?
Coloring Agents
1
2019
70
0.040
 Why?
Gene Dosage
1
2018
78
0.040
 Why?
Histone Demethylases
1
2018
17
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Leptin
1
2019
143
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2018
49
0.040
 Why?
Estradiol
1
2019
215
0.040
 Why?
Major Histocompatibility Complex
1
2017
12
0.040
 Why?
Databases, Genetic
1
2018
88
0.040
 Why?
Genotyping Techniques
1
2017
20
0.040
 Why?
Child
4
2018
6877
0.040
 Why?
Chemokines
1
2017
76
0.040
 Why?
Receptors, Collagen
1
1997
3
0.040
 Why?
Receptors, Fibronectin
1
1997
5
0.040
 Why?
Mass Screening
1
2000
348
0.040
 Why?
Time Factors
4
2010
2934
0.040
 Why?
Coculture Techniques
1
2017
143
0.040
 Why?
Transforming Growth Factor beta
1
2018
136
0.040
 Why?
Interferon-gamma
1
2018
176
0.040
 Why?
Integrins
1
1997
30
0.040
 Why?
Chemotherapy, Adjuvant
2
2010
121
0.030
 Why?
Quality-Adjusted Life Years
2
2010
63
0.030
 Why?
Diet, High-Fat
1
2019
214
0.030
 Why?
Epithelial Cells
2
2006
210
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Longitudinal Studies
1
2019
709
0.030
 Why?
Herpesviridae
1
2016
17
0.030
 Why?
Viruses
1
2016
21
0.030
 Why?
Host-Pathogen Interactions
1
2017
136
0.030
 Why?
Mice, Transgenic
1
2017
543
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
40
0.030
 Why?
DNA Replication
1
1997
151
0.030
 Why?
Cost-Benefit Analysis
2
2010
270
0.030
 Why?
Plasmids
2
2001
164
0.030
 Why?
Sequence Analysis, RNA
1
2016
88
0.030
 Why?
Central Nervous System Neoplasms
1
2016
64
0.030
 Why?
Electrosurgery
1
1995
7
0.030
 Why?
Fibroblasts
1
2017
354
0.030
 Why?
Macrophages
1
2018
363
0.030
 Why?
Prostatic Neoplasms
1
1998
394
0.030
 Why?
CpG Islands
2
2008
106
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Arteries
1
1995
91
0.030
 Why?
Computational Biology
1
2016
215
0.030
 Why?
Cytokines
1
2017
606
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
17
0.030
 Why?
Multivariate Analysis
2
2009
583
0.030
 Why?
Treatment Failure
2
2008
115
0.030
 Why?
Missouri
2
2006
64
0.030
 Why?
Organs at Risk
1
2014
70
0.030
 Why?
Inclusion Bodies
1
1993
18
0.030
 Why?
Cell Division
2
1994
294
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
22
0.030
 Why?
Cell Death
1
2014
174
0.030
 Why?
Imaging, Three-Dimensional
1
2014
152
0.030
 Why?
Risk
2
2004
316
0.030
 Why?
Skin Physiological Phenomena
1
1992
15
0.030
 Why?
Guinea Pigs
1
1992
75
0.030
 Why?
Epidermis
1
1992
28
0.030
 Why?
Pelvis
2
2004
67
0.030
 Why?
Pedigree
2
2004
125
0.020
 Why?
Deoxyglucose
1
2012
36
0.020
 Why?
Colectomy
1
1992
34
0.020
 Why?
Regeneration
1
1992
74
0.020
 Why?
Computer Simulation
1
2012
284
0.020
 Why?
Pilot Projects
2
2004
704
0.020
 Why?
Sequence Deletion
2
2003
69
0.020
 Why?
Premenopause
1
2010
26
0.020
 Why?
Amino Acid Sequence
2
2003
579
0.020
 Why?
Staurosporine
1
2010
12
0.020
 Why?
Anastomosis, Surgical
1
1990
66
0.020
 Why?
Remission Induction
1
2010
206
0.020
 Why?
Molecular Weight
1
1990
85
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
66
0.020
 Why?
ras Proteins
2
2001
65
0.020
 Why?
Hemoglobins
1
1990
106
0.020
 Why?
Cicatrix
1
1990
43
0.020
 Why?
Staining and Labeling
1
1990
97
0.020
 Why?
Chi-Square Distribution
1
2010
280
0.020
 Why?
Perioperative Care
1
2009
42
0.020
 Why?
Urinary Incontinence
1
2009
38
0.020
 Why?
Organoplatinum Compounds
1
2008
15
0.020
 Why?
Gene Knockdown Techniques
1
2009
106
0.020
 Why?
Vinblastine
1
2008
23
0.020
 Why?
Fetus
1
1990
218
0.020
 Why?
Life Style
1
2009
140
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
184
0.020
 Why?
Emotions
1
2009
166
0.020
 Why?
Cell Line
1
1990
1010
0.020
 Why?
Cadherins
1
2007
64
0.020
 Why?
Demography
1
2007
93
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
139
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
DNA Mismatch Repair
1
2006
16
0.020
 Why?
Skin
1
1990
417
0.020
 Why?
Waxes
1
2006
1
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
16
0.020
 Why?
NIH 3T3 Cells
1
2006
51
0.020
 Why?
Immunoenzyme Techniques
2
2001
141
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
12
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
161
0.020
 Why?
Cryopreservation
1
2006
31
0.020
 Why?
Analysis of Variance
1
2007
562
0.020
 Why?
Transfection
1
2006
354
0.020
 Why?
Mutation, Missense
1
2006
104
0.020
 Why?
Nurse Practitioners
1
2006
42
0.020
 Why?
Gene Expression
1
2008
613
0.020
 Why?
Gynecology
1
2006
49
0.020
 Why?
Early Diagnosis
1
2006
88
0.020
 Why?
Medical Futility
1
2005
8
0.020
 Why?
Ovarian Cysts
1
2005
4
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Cyclophosphamide
1
2006
164
0.020
 Why?
Triage
1
2006
61
0.020
 Why?
Leiomyosarcoma
1
2005
23
0.020
 Why?
Hospice Care
1
2005
26
0.020
 Why?
Cytodiagnosis
1
2005
42
0.020
 Why?
Health Services
1
2005
65
0.020
 Why?
Phosphorylation
1
2006
527
0.020
 Why?
Obstetrics
1
2006
88
0.020
 Why?
Lymphatic System
1
2004
13
0.010
 Why?
Penetrance
1
2004
6
0.010
 Why?
Area Under Curve
1
2004
179
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
75
0.010
 Why?
Calcification, Physiologic
1
2004
40
0.010
 Why?
Laparotomy
1
2004
35
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
16
0.010
 Why?
Ethanol
1
2006
336
0.010
 Why?
Genomic Instability
1
2004
91
0.010
 Why?
Tamoxifen
1
2004
59
0.010
 Why?
Thrombospondin 1
1
2003
7
0.010
 Why?
Genes, p16
1
2003
9
0.010
 Why?
Confidence Intervals
1
2003
154
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Administration, Oral
1
2004
432
0.010
 Why?
Frameshift Mutation
1
2003
17
0.010
 Why?
Liposomes
1
2003
52
0.010
 Why?
Mutagenesis, Insertional
1
2003
24
0.010
 Why?
Palliative Care
1
2005
188
0.010
 Why?
Body Weight
1
2005
514
0.010
 Why?
Cytoskeletal Proteins
1
2003
49
0.010
 Why?
DNA Transposable Elements
1
2003
105
0.010
 Why?
Physicians
1
2006
229
0.010
 Why?
Prevalence
1
2006
970
0.010
 Why?
Reference Values
1
2003
312
0.010
 Why?
beta Catenin
1
2003
101
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
Retinoblastoma Protein
1
2002
18
0.010
 Why?
Ifosfamide
1
2002
8
0.010
 Why?
Documentation
1
2002
33
0.010
 Why?
Trans-Activators
1
2003
135
0.010
 Why?
Bleomycin
1
2002
34
0.010
 Why?
Hospitals, University
1
2002
78
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
74
0.010
 Why?
Age Distribution
1
2002
170
0.010
 Why?
Equipment Failure
1
2001
63
0.010
 Why?
Statistics, Nonparametric
1
2002
193
0.010
 Why?
Nucleic Acid Hybridization
2
1991
55
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
77
0.010
 Why?
Carcinoma, Small Cell
1
2001
25
0.010
 Why?
Genes, erbB-1
1
2001
8
0.010
 Why?
Radiography
1
2002
485
0.010
 Why?
Outpatients
1
2002
115
0.010
 Why?
Hospitalization
1
2005
668
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
96
0.010
 Why?
DNA
1
2004
543
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
154
0.010
 Why?
Genetic Linkage
1
2000
26
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
 Why?
Morbidity
1
2000
135
0.010
 Why?
Blotting, Western
1
2001
587
0.010
 Why?
Gene Deletion
1
2000
267
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
152
0.010
 Why?
Chromosomes, Bacterial
1
1998
14
0.010
 Why?
Cloning, Molecular
1
1998
189
0.010
 Why?
Infant
1
2006
3601
0.010
 Why?
Child, Preschool
1
2006
3908
0.010
 Why?
Drug Resistance, Multiple
1
1997
24
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
67
0.010
 Why?
Gene Frequency
1
1997
95
0.010
 Why?
United States
1
2007
4913
0.010
 Why?
Dimethyl Sulfoxide
1
1994
12
0.010
 Why?
Glycerol
1
1994
15
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
52
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
131
0.010
 Why?
Drug Carriers
1
1994
70
0.010
 Why?
Cell Cycle
1
1994
227
0.010
 Why?
Retroperitoneal Space
1
1991
32
0.010
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (633) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (37) people
_
Same Department Expand Description
Search Department